BridgeMD
New treatment option for Infertility
Official title Effect of Antioxydant-enriched Media on Blastocyst Euploidy Rates.
ClinicalTrials.gov ID: NCT06261671
What this study is testing
What is antioxidants-enriched culture medium (Gx)?
antioxidants-enriched culture medium (Gx) is an investigational medicine, being studied as a potential treatment for infertility.
Also referred to as Global total one step media (GT).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- One of the most sensible factors in IVF culture conditions is the susceptibility of gametes and embryos to an induced increase in reactive oxidative species (ROS) caused by the artificial environment. This study aims to evaluate the impact of using antioxidant-supplemented media during culture to evaluate embryo ploidy rates in a prospective randomized trial using sibling oocytes.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 43. Healthy volunteers may be eligible.
You may be able to join if
- Patients undergoing assisted reproductive technology cycles when ICSI is indicated.
- Patients when Iin vitto fertilization (IVF) is also performed will be included as far as there are enough oocytes for ICSI randomization. However...
- Maternal age 18-43 years old.
- PGT-A cycles with only trophectoderm biopsies on day 5/6/7.
- Patients with more than 6 COCs expected for ICSI.
You likely can't join if
- PGT-M cycles
- Fresh and frozen testicular sperm.
See the full eligibility criteria
- Patients undergoing assisted reproductive technology cycles when ICSI is indicated.
- Patients when Iin vitto fertilization (IVF) is also performed will be included as far as there are enough oocytes for ICSI randomization. However, IVF oocytes will not be used for the study.
- Maternal age 18-43 years old.
- PGT-A cycles with only trophectoderm biopsies on day 5/6/7.
- Patients with more than 6 COCs expected for ICSI.
- Body mass index \<35.
- Fresh and frozen ejaculated sperm.
- PGT-M cycles
- Fresh and frozen testicular sperm.
The study team makes the final eligibility decision.
Where it's taking place
- Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 43 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.